美國Devatal
美國Devatal公司成立于2003年,以開發專有技術生產的重組蛋白和單克隆抗體為主。公司利用膠體金及熒光檢測技術為傳染病和其他檢測分析開發快速診斷測試。
Devatal公司的專業知識和技術重點在以下領域: 開發與艾滋病病毒、人體T細胞白血病病毒、肝炎相應的優質重組蛋白以及其他相關的蛋白;開發快速、簡便的診斷試驗;為研究和診斷領域開發單克隆抗體及其他免疫試劑。
DevaTal manufactures biological products for basic research, clinical research, and clinical diagnostic markets. Our biological reagents are used in life science research, for immunological detection of infectious diseases and other analytes. We produce recombinant proteins, monoclonal antibodies, and other research reagents.
DevaTal focuses its expertise and technology to produce a wide range of Cytokines, Growth Factors, Chemokines, Hormones, Enzymes, Viral Antigens, Monoclonal antibodies, and many other Recombinant Proteins. This includes the development and marketing of superior recombinant proteins corresponding to HIV, HTLV, hepatitis, other viral proteins, and other immuno-reagents required for Research and Diagnostic purposes.
The company uses both direct and indirect sales through strategic alliances in various market segments. DevaTal has R&D contracts with key Biopharmaceutical and diagnostic corporations in both the USA and offshore. We provide the technology and know-how for the production of large-scale production of Recombinant Proteins. These relationships are based on OEM, royalties, and profit sharing agreements.